1 asset in Meningococcal Infection
Therapeutic assets addressing Meningococcal Infection, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Trumenba Meningococcal Infection | Pfizer | P4 | BB (69) |
Therapeutic assets addressing Meningococcal Infection, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Trumenba Meningococcal Infection | Pfizer | P4 | BB (69) |